 | • レポートコード：D0GIR-02211 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、鎌状赤血球の世界市場を広く調査・分析し、今後の市場展望をまとめております。鎌状赤血球の種類別市場規模（診断、治療）、用途別市場規模（病院、クリニック、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Bluebird Bio、Bristol-Myers Squibb、Takeda、Global Blood Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・鎌状赤血球の北米市場（アメリカ、カナダ、メキシコ） ・鎌状赤血球のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・鎌状赤血球のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・鎌状赤血球の南米市場（ブラジル、アルゼンチン） ・鎌状赤血球の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：診断、治療 ・用途別分析：病院、クリニック、外来手術センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Sickle Cell market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sickle Cell market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sickle Cell market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sickle Cell market has been segmented into:
Diagnosis
Treatment
By Application, Sickle Cell has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sickle Cell market presented in the report. This section sheds light on the sales growth of different regional and country-level Sickle Cell markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sickle Cell market.
The report offers in-depth assessment of the growth and other aspects of the Sickle Cell market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sickle Cell Market Share Analysis
Sickle Cell competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sickle Cell sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sickle Cell sales, revenue and market share for each player covered in this report.
The major players covered in Sickle Cell are:
Novartis
Bluebird Bio
Bristol-Myers Squibb
Takeda
Global Blood Therapeutics
Table of Contents
1 Sickle Cell Market Overview
1.1 Product Overview and Scope of Sickle Cell
1.2 Classification of Sickle Cell by Type
1.2.1 Global Sickle Cell Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sickle Cell Revenue Market Share by Type in 2019
1.2.3 Diagnosis
1.2.4 Treatment
1.3 Global Sickle Cell Market by Application
1.3.1 Overview: Global Sickle Cell Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Sickle Cell Market by Regions
1.4.1 Global Sickle Cell Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sickle Cell (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sickle Cell Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sickle Cell Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sickle Cell Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sickle Cell Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sickle Cell Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Sickle Cell Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bluebird Bio
2.2.1 Bluebird Bio Details
2.2.2 Bluebird Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bluebird Bio SWOT Analysis
2.2.4 Bluebird Bio Product and Services
2.2.5 Bluebird Bio Sickle Cell Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Sickle Cell Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Sickle Cell Revenue, Gross Margin and Market Share (2018-2019)
2.5 Global Blood Therapeutics
2.5.1 Global Blood Therapeutics Details
2.5.2 Global Blood Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Global Blood Therapeutics SWOT Analysis
2.5.4 Global Blood Therapeutics Product and Services
2.5.5 Global Blood Therapeutics Sickle Cell Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sickle Cell Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sickle Cell Players Market Share
3.2.2 Top 10 Sickle Cell Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sickle Cell Revenue and Market Share by Regions
4.2 North America Sickle Cell Revenue and Growth Rate (2015-2020)
4.3 Europe Sickle Cell Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sickle Cell Revenue and Growth Rate (2015-2020)
4.5 South America Sickle Cell Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sickle Cell Revenue and Growth Rate (2015-2020)
5 North America Sickle Cell Revenue by Countries
5.1 North America Sickle Cell Revenue by Countries (2015-2020)
5.2 USA Sickle Cell Revenue and Growth Rate (2015-2020)
5.3 Canada Sickle Cell Revenue and Growth Rate (2015-2020)
5.4 Mexico Sickle Cell Revenue and Growth Rate (2015-2020)
6 Europe Sickle Cell Revenue by Countries
6.1 Europe Sickle Cell Revenue by Countries (2015-2020)
6.2 Germany Sickle Cell Revenue and Growth Rate (2015-2020)
6.3 UK Sickle Cell Revenue and Growth Rate (2015-2020)
6.4 France Sickle Cell Revenue and Growth Rate (2015-2020)
6.5 Russia Sickle Cell Revenue and Growth Rate (2015-2020)
6.6 Italy Sickle Cell Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sickle Cell Revenue by Countries
7.1 Asia-Pacific Sickle Cell Revenue by Countries (2015-2020)
7.2 China Sickle Cell Revenue and Growth Rate (2015-2020)
7.3 Japan Sickle Cell Revenue and Growth Rate (2015-2020)
7.4 Korea Sickle Cell Revenue and Growth Rate (2015-2020)
7.5 India Sickle Cell Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sickle Cell Revenue and Growth Rate (2015-2020)
8 South America Sickle Cell Revenue by Countries
8.1 South America Sickle Cell Revenue by Countries (2015-2020)
8.2 Brazil Sickle Cell Revenue and Growth Rate (2015-2020)
8.3 Argentina Sickle Cell Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sickle Cell by Countries
9.1 Middle East & Africa Sickle Cell Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sickle Cell Revenue and Growth Rate (2015-2020)
9.3 UAE Sickle Cell Revenue and Growth Rate (2015-2020)
9.4 Egypt Sickle Cell Revenue and Growth Rate (2015-2020)
9.5 South Africa Sickle Cell Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sickle Cell Revenue and Market Share by Type (2015-2020)
10.2 Global Sickle Cell Market Forecast by Type (2019-2024)
10.3 Diagnosis Revenue Growth Rate (2015-2025)
10.4 Treatment Revenue Growth Rate (2015-2025)
11 Global Sickle Cell Market Segment by Application
11.1 Global Sickle Cell Revenue Market Share by Application (2015-2020)
11.2 Sickle Cell Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Sickle Cell Market Size Forecast (2021-2025)
12.1 Global Sickle Cell Market Size Forecast (2021-2025)
12.2 Global Sickle Cell Market Forecast by Regions (2021-2025)
12.3 North America Sickle Cell Revenue Market Forecast (2021-2025)
12.4 Europe Sickle Cell Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sickle Cell Revenue Market Forecast (2021-2025)
12.6 South America Sickle Cell Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sickle Cell Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sickle Cell Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sickle Cell by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sickle Cell Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sickle Cell Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Sickle Cell Major Business
Table 7. Novartis Sickle Cell Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Sickle Cell Product and Solutions
Table 10. Novartis Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bluebird Bio Corporate Information, Location and Competitors
Table 12. Bluebird Bio Sickle Cell Major Business
Table 13. Bluebird Bio Sickle Cell Total Revenue (USD Million) (2018-2019)
Table 14. Bluebird Bio SWOT Analysis
Table 15. Bluebird Bio Sickle Cell Product and Solutions
Table 16. Bluebird Bio Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Sickle Cell Major Business
Table 19. Bristol-Myers Squibb Sickle Cell Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb SWOT Analysis
Table 21. Bristol-Myers Squibb Sickle Cell Product and Solutions
Table 22. Bristol-Myers Squibb Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Takeda Corporate Information, Location and Competitors
Table 24. Takeda Sickle Cell Major Business
Table 25. Takeda Sickle Cell Total Revenue (USD Million) (2017-2018)
Table 26. Takeda SWOT Analysis
Table 27. Takeda Sickle Cell Product and Solutions
Table 28. Takeda Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Global Blood Therapeutics Corporate Information, Location and Competitors
Table 30. Global Blood Therapeutics Sickle Cell Major Business
Table 31. Global Blood Therapeutics Sickle Cell Total Revenue (USD Million) (2017-2018)
Table 32. Global Blood Therapeutics SWOT Analysis
Table 33. Global Blood Therapeutics Sickle Cell Product and Solutions
Table 34. Global Blood Therapeutics Sickle Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Sickle Cell Revenue (Million USD) by Players (2015-2020)
Table 36. Global Sickle Cell Revenue Share by Players (2015-2020)
Table 37. Global Sickle Cell Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Sickle Cell Revenue Market Share by Regions (2015-2020)
Table 39. North America Sickle Cell Revenue by Countries (2015-2020)
Table 40. North America Sickle Cell Revenue Market Share by Countries (2015-2020)
Table 41. Europe Sickle Cell Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Sickle Cell Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Sickle Cell Revenue by Countries (2015-2020)
Table 44. South America Sickle Cell Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Sickle Cell Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Sickle Cell Revenue Market Share by Countries (2015-2020)
Table 47. Global Sickle Cell Revenue (Million USD) by Type (2015-2020)
Table 48. Global Sickle Cell Revenue Share by Type (2015-2020)
Table 49. Global Sickle Cell Revenue Forecast by Type (2021-2025)
Table 50. Global Sickle Cell Revenue by Application (2015-2020)
Table 51. Global Sickle Cell Revenue Share by Application (2015-2020)
Table 52. Global Sickle Cell Revenue Forecast by Application (2021-2025)
Table 53. Global Sickle Cell Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sickle Cell Picture
Figure 2. Global Sickle Cell Revenue Market Share by Type in 2019
Figure 3. Diagnosis Picture
Figure 4. Treatment Picture
Figure 5. Sickle Cell Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Global Sickle Cell Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Sickle Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Sickle Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Sickle Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Sickle Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Sickle Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Sickle Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Sickle Cell Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Sickle Cell Revenue Market Share in 2019
Figure 18. Global Top 10 Players Sickle Cell Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Sickle Cell Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Sickle Cell Revenue Market Share by Regions (2015-2020)
Figure 22. Global Sickle Cell Revenue Market Share by Regions in 2018
Figure 23. North America Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 24. Europe Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 26. South America Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 28. North America Sickle Cell Revenue Market Share by Countries (2015-2020)
Figure 29. North America Sickle Cell Revenue Market Share by Countries in 2019
Figure 30. USA Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 31. Canada Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 33. Europe Sickle Cell Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Sickle Cell Revenue Market Share by Countries in 2019
Figure 35. Germany Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 36. UK Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 37. France Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 38. Russia Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 39. Italy Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Sickle Cell Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Sickle Cell Revenue Market Share by Countries in 2019
Figure 42. China Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 43. Japan Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 44. Korea Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 45. India Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 47. South America Sickle Cell Revenue Market Share by Countries (2015-2020)
Figure 48. South America Sickle Cell Revenue Market Share by Countries in 2019
Figure 49. Brazil Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Sickle Cell Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Sickle Cell Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 54. UAE Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Sickle Cell Revenue and Growth Rate (2015-2020)
Figure 57. Global Sickle Cell Revenue Share by Type (2015-2020)
Figure 58. Global Sickle Cell Revenue Share by Type in 2019
Figure 59. Global Sickle Cell Market Share Forecast by Type (2021-2025)
Figure 60. Global Diagnosis Revenue Growth Rate (2015-2020)
Figure 61. Global Treatment Revenue Growth Rate (2015-2020)
Figure 62. Global Sickle Cell Revenue Share by Application (2015-2020)
Figure 63. Global Sickle Cell Revenue Share by Application in 2019
Figure 64. Global Sickle Cell Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Sickle Cell Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Sickle Cell Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Sickle Cell Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Sickle Cell Revenue Market Forecast (2021-2025)
Figure 72. Europe Sickle Cell Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Sickle Cell Revenue Market Forecast (2021-2025)
Figure 74. South America Sickle Cell Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Sickle Cell Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
鎌状赤血球症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Sickle Cell Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sickle Cell Di…- 皮膚B細胞リンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous B-Cell Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- B細胞性非ホジキンリンパ腫（NHL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 形質細胞腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Plasma Cell Neoplasm Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma Cell Ne…
- 末梢T細胞リンパ腫（PTCL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Peripheral T-Cell Lymphoma (PTCL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…